Regeneron Pharmaceuticals and Sanofi have received FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in continual obstructive pulmonary illness.
in Business
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Don't have an account? Register
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website. GDPR Privacy policy
AcceptHere you'll find all collections you've created before.
